Crossmark

Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia

Crossref DOI link: https://doi.org/10.1186/s12943-018-0805-1

Published Online: 2018-02-19

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Massimino, Michele

Stella, Stefania

Tirrò, Elena

Romano, Chiara

Pennisi, Maria Stella

Puma, Adriana

Manzella, Livia

Zanghì, Antonino

Stagno, Fabio

Di Raimondo, Francesco

Vigneri, Paolo http://orcid.org/0000-0002-5943-6066
Funding

Funding for this research was provided by:

AIRC (IG12958)
More Information

Article History

Received: 26 October 2017

Accepted: 1 February 2018

First Online: 19 February 2018

Competing interests

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.